Citius PharmaceuticalsCTXR
那斯達克 · USD
1.40
+0.03
(+2.19%)
收盤 08/29 03:52 (UTC+8)
盤後
1.40
1.40
(0.00%)
08/29 03:52 (UTC+8)
Citius PharmaceuticalsCTXR
1.40
+0.03
(+2.19%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 0.00
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | |
營業收入淨額 | 0 | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 0 | - | - | - | - | - | - | - | - | - |
營業費用 | 8,788 | - | - | - | - | - | 9,341 | 10,125 | 8,672 | 10,685 |
研發費用 | 1,621 | 3,767 | 2,127 | 2,915 | 2,764 | 3,606 | 2,622 | 2,883 | 3,765 | 4,727 |
推銷及管理費用 | 7,167 | 7,494 | 7,913 | 8,136 | 7,870 | 7,364 | 6,719 | 7,242 | 4,907 | 5,958 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -8,788 | -11,261 | -10,040 | -11,050 | -10,634 | -10,970 | -9,341 | -10,125 | -8,672 | -10,685 |
其他收入及費用 | - | 13 | 23 | 117 | 205 | 2,570 | 254 | 325 | 337 | 303 |
利息費用 | 172 | - | - | - | - | - | - | - | - | - |
稅前純益 | -8,940 | -11,247 | -10,017 | -10,933 | -10,429 | -8,400 | -9,087 | -9,800 | -8,335 | -10,382 |
所得稅 | 264 | 264 | 264 | 144 | 144 | 144 | 144 | 144 | 144 | 144 |
稅後純益 | -8,790 | -10,917 | -9,768 | -10,790 | -10,573 | -8,544 | -9,231 | -9,944 | -8,479 | -10,526 |
基本每股稅後盈餘(元) | -0.80 | -1.27 | -1.30 | -0.07 | -0.06 | -0.05 | -0.06 | - | -0.06 | -0.07 |
稀釋每股稅後盈餘(元) | -0.80 | -1.28 | -1.30 | -0.07 | -0.06 | -0.05 | -0.06 | -0.07 | -0.05 | -0.08 |
基本平均股數(千股) | 11006.00 | 8581.00 | 7492.00 | 180849.00 | 173856.00 | 159072.00 | 158955.00 | - | 153775.00 | 146251.00 |
稀釋平均股數(千股) | 11006.00 | 8581.00 | 7492.00 | 180849.00 | 173856.00 | 159072.00 | 158955.00 | - | 153775.00 | 146251.00 |
還原基本每股稅後盈餘(元) | -0.80 | -1.27 | -1.30 | -1.68 | -1.57 | -1.34 | -1.45 | - | -1.50 | -1.75 |
還原稀釋每股稅後盈餘(元) | -0.80 | -1.28 | -1.30 | -1.72 | -1.46 | -1.34 | -1.45 | -1.82 | -1.25 | -2.00 |
還原基本平均股數(千股) | 11,006 | 8,581 | 7,492 | 7,233 | 6,954 | 6,362 | 6,358 | - | 6,151 | 5,850 |
還原稀釋平均股數(千股) | 11,006 | 8,581 | 7,492 | 7,233 | 6,954 | 6,362 | 6,358 | - | 6,151 | 5,850 |
EBITDA(千元) | -8,313 | -10,597 | -9,449 | -10,592 | -10,376 | -8,348 | -9,036 | -9,750 | -8,286 | -10,334 |